25678790|t|The association of post-stroke anhedonia with salivary cortisol levels and stroke lesion in hippocampal/parahippocampal region.
25678790|a|BACKGROUND: Anhedonia constitutes a coherent construct, with neural correlates and negative clinical impact, independent of depression. However, little is known about the neural correlates of anhedonia in stroke patients. In this study, we investigated the association of post-stroke anhedonia with salivary cortisol levels and stroke location and volume. PATIENTS AND METHODS: A psychiatrist administered the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition to identify anhedonia in 36 inpatients, without previous depression, consecutively admitted in a neurology clinic in the first month after a first-ever ischemic stroke. Salivary cortisol levels were assessed in the morning, evening, and after a dexamethasone suppression test. We used magnetic resonance imaging and a semi-automated brain morphometry method to assess stroke location, and the MRIcro program according to the Brodmann Map to calculate the lesion volume. RESULTS: Patients with anhedonia had significantly larger diurnal variation (P-value =0.017) and higher morning levels of salivary cortisol (1,671.9+-604.0 ng/dL versus 1,103.9+-821.9 ng/dL; P-value =0.022), and greater stroke lesions in the parahippocampal gyrus (Brodmann area 36) compared to those without anhedonia (10.14 voxels; standard deviation +-17.72 versus 0.86 voxels; standard deviation +-4.64; P-value =0.027). The volume of lesion in the parahippocampal gyrus (Brodmann area 36) was associated with diurnal variation of salivary cortisol levels (rho=0.845; P-value =0.034) only in anhedonic patients. CONCLUSION: Our findings suggest that anhedonia in stroke patients is associated with the volume of stroke lesion in the parahippocampal gyrus and with dysfunction of the hypothalamic-pituitary-adrenal axis.
25678790	19	30	post-stroke	Disease	MESH:D020521
25678790	31	40	anhedonia	Disease	MESH:D059445
25678790	55	63	cortisol	Chemical	MESH:D006854
25678790	75	88	stroke lesion	Disease	MESH:D020521
25678790	140	149	Anhedonia	Disease	MESH:D059445
25678790	252	262	depression	Disease	MESH:D003866
25678790	320	329	anhedonia	Disease	MESH:D059445
25678790	333	339	stroke	Disease	MESH:D020521
25678790	340	348	patients	Species	9606
25678790	400	411	post-stroke	Disease	MESH:D020521
25678790	412	421	anhedonia	Disease	MESH:D059445
25678790	436	444	cortisol	Chemical	MESH:D006854
25678790	456	462	stroke	Disease	MESH:D020521
25678790	484	492	PATIENTS	Species	9606
25678790	609	625	Mental Disorders	Disease	MESH:D001523
25678790	654	663	anhedonia	Disease	MESH:D059445
25678790	670	680	inpatients	Species	9606
25678790	699	709	depression	Disease	MESH:D003866
25678790	794	809	ischemic stroke	Disease	MESH:D002544
25678790	820	828	cortisol	Chemical	MESH:D006854
25678790	887	900	dexamethasone	Chemical	MESH:D003907
25678790	1010	1016	stroke	Disease	MESH:D020521
25678790	1121	1129	Patients	Species	9606
25678790	1135	1144	anhedonia	Disease	MESH:D059445
25678790	1243	1251	cortisol	Chemical	MESH:D006854
25678790	1332	1346	stroke lesions	Disease	MESH:D020521
25678790	1421	1430	anhedonia	Disease	MESH:D059445
25678790	1656	1664	cortisol	Chemical	MESH:D006854
25678790	1708	1717	anhedonic	Disease	
25678790	1718	1726	patients	Species	9606
25678790	1766	1775	anhedonia	Disease	MESH:D059445
25678790	1779	1785	stroke	Disease	MESH:D020521
25678790	1786	1794	patients	Species	9606
25678790	1828	1841	stroke lesion	Disease	MESH:D020521
25678790	1880	1934	dysfunction of the hypothalamic-pituitary-adrenal axis	Disease	MESH:D007027
25678790	Association	MESH:D006854	MESH:D020521
25678790	Positive_Correlation	MESH:D006854	MESH:D059445

